CRISPR-Cas9 (RNP)

A Reum Han1, Ha Rim Shin2, Jiyeon Kwon3

  • 1Department of Translational Medicine and Department of Biochemistry and Molecular Biology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505; Stem Cell Immunomodulation Research Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

BMB reports
|December 6, 2023
PubMed
概括

与等离子体DNA相比,核蛋白 (RNP) 复合体在介质干细胞 (MSC) 中提供了优越的基因组工程. 这种优化的CRISPR-Cas9 RNP方法通过提高编辑效率和减少细胞毒性来增强MSC的治疗潜力.